فناوری

Full Name: Soosan . Soroosh

Associated professor

Address:

Private office: 230, Motahari St., Tehran 15888, Iran

Telephone: +98 21 882 83 35

Cell phone: 09121329865

Fax: +98 21 883 084 44

ZIP: 1991735481

E-mail address: soroosh44@yahoo.com

NATIONALITY: Iranian

DATE OF BIRTH: April/ 12/ 1965

MEDICAL EDUCATION:

Tehran University for Medical Sciences, School of Medicine, from February, 1983 to August 1989, Tehran, Iran. M D graduate: 1989.

POSTGRADUATE MEDICAL TRAINING:

Residency of Internal Medicine: Tehran University for Medical Sciences, School of Medicine, Shariati Hospital. Residency of Internal Medicine From January 1989 to August1994. National board of Internal Medicine: 1997.

Subspecialty:

Fellowship of Rheumatology Subspecialty: Tehran University for Medical Sciences, School of Medicine, Shariati Hospital. From October1994 to August 1997. National Board of Rheumatology Subspecialty: 1997.

PROFESSIONAL APPOINTMENTS

Assistant Professor of Internal Medicine, Division of Rheumatology, Imam Hospital, Tehran University for Medical Sciences, School of Medicine, Tehran, Iran. From March 1997 to August 2000.

Assistant Professor of Internal Medicine, Division of Rheumatology, Hospital 501, Military University for Medical Sciences, School of Medicine. Tehran, Iran. From April 2001 until now,

President of 4th and 11th Iranian rheumatology association

MEMBERSHIP(S)

Iranian Rheumatology Association

Asisan – Passific League of Rheumatology( APLAR)

HONOURS/AWARDS

APLAR scholarship in 1996

Tehran University’s Award for the best annual book on Rheumatology in 1999

Tehran University’s Award for the best annual book on Rheumatology in 2000

Tehran University’s Award for the best annual book on Rheumatology in 2001

Tehran University’s Award for the best annual book on Rheumatology in 2002

APLAR scholarship in 2004

PUBLICATIONS

Articles:

1. Soroosh G S, Shahram F, Akbarian M, Gharibdoost F, Davatchi F. Effect of intramuscular Gold therapy on the course of rheumatoid arthritis. Acta Medica Iranica 1996; 34: 1- 6

2. Soroosh G S, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Jamshidi A, Davatchi F. Overlap of connective tissue diseases evaluation of 119 cases. Acta Medica Iranica1998;36: 1- 8

3. Soroosh G S, Akbarian M, Davatchi F, Shahram F, Nadji A, Gharibdoost F, Jamshidi A R. Outcome measurement of type IV systemic Lupus nephritis by classification and regression tree (CART). APLAR journal of Rheumatology 2000; 4:108- 113

4. Soroosh G S, Soroosh G M, Dastjerdi M F, Farahvash M H, Naderi A, Vahedi H. The differences between manifestation of rheumatoid arthritis in men and women. APLAR journal of Rheumatology 2005; 8:203- 206

5. Soroosh S. dairy consumption and related disease in personel of Military educating hospital and dormitory. Journal of Army university of medical sciences of the I.R.Iran, 2008;6:159- 161.

ا

Abstract Books( International congresses)

1. Gharibdoost F, Shahram F, Davatchi F, Nadji A, M. Akbarian, Jamshidi A, Farahvash H, Soroosh G S. Treatment of osteoporosis by Natrium Fluoride(Na F). Proceedings of the 8th APLAR Congress of Rheumatology; 1996 April; Melbourne, Australia: Posters P92, Abstract 336.

2. Gharibdoost F, Davatchi F, Shahram F, Akbarian M, Nadji A, Farahvash H, Jamshidi A, Soroosh G S. Estrogen(HRT) versus HRT and Natrium Fluoride(Na F) in menopausal osteoporosis. Proceedings of the 8th. APLAR Congress of Rheumatology; 1996 April; Melbourne, Australia: Posters P92, Abstract 337.10.11.

3. Soroosh G S, Gharibdoost F, Davatchi F, Shahram F, Zolfaghari M E, Akbarian M, Nadji A, Jamshidi A. Natrium Fluoride (Na F) for the treatment of osteoporosis In Rheumatoid Arthritis (RA); Proceedings of the 8th APLAR Congress of Rheumatology; 1996 April; Melbourne, Australia: Posters P 91.

4. Davatchi F, Soroosh S G, Shahram F, Chams H, Akbarian M, Gharibdoost F, Nadji A, Chams C. Outcome measurement of ocular lesions in Behcet‘s Disease. In: Hamza M. (ed). Behcet’s Disease. Tunisia: PUB ADHOUA; 1997. 238- 241.

5. Davatchi F, Shahram F, Chams H, Akbarian M, Nadji A, Chams C, Gharibdoost F, Jamshidi A, Soroosh G S. Azathioprine for the treatment of ophthalmologic lesions of Behcet’s disease. Proceedings of the 8th International Congress on Behcet’s Disease; 1998 October; Reggio Emilia, Italy: Abstract p125, p. 236.

6. Shafaei F, Shahram F, Davatchi F, Nadji A, Akbarian M, Gharibdoost F, Soroosh G S. Comparison of juvenile with adult Behcet’s disease. Arthritis Rheum 1998; 41: 9 (suppl): Abstract 551, p.S124.

7. Davatchi F, Shahram F, Chams H, Akbarian M, Nadji A, Gharibdoost F, Chams C, Jamshidi A R, Soroosh G S. Methotrexate for ocular Lesions of Behcet’s disease, cohort study on 262 patients. Arthritis &Rheumatism1998; 41:9 (Suppl): Abstract 1940, p.S356.

8. Soroosh G S, Davatchi F, Shahram F, Chams H, Akbarian M, Gharibdoost F,Nadji A, Chams C. Outcome measurement of ocular lesions in Behcet’s disease. Proceedings of the 9th. Asia Pacific League of Associations for Rheumatology Congress; 2000 May; Beijing, China: p.128.

9. Soroosh G S, Pasalar P, Samini M, Tootoonchi H, Nadimifarokh A. The effect of combined drug treatment using Chloroquine and Methotrexate on the status of antioxidant capacity of plasma in rheumatoid arthritis. The 20th. Congress of the International League of Associations for Rheumatology; 2001 August; Edmonton, Canada: J Rheumatol 2001 July; 28: 102.

10. Soroosh G S, Pasalar P, Farahvash M H. The quantity of plasma antioxidant defenses in rheumatoid arthritis patients in comparison to normal. The 10th. Asia Pacific League of Associations for Rheumatology Congress; 2002 December; Bangkok, Thailand: 18.

11. Soroosh G S, Farahvash M H. The clinical manifestations of reactive arthritis(ReA), A study in 62 cases observed in Iran. Annual European Congress of Rheumatology 2003 June, Lisbon: Ann Rheum Dis; 62: 523.

12. Soroosh G S, Pasalar P, Sarafnejad A, Khoramizadeh M. Prospective studies on Reactive Arthritis in Military sevice. The 11th. Asia Pacific League of Associations for Rheumatology Congress; 2004 September; Jeju, Korea: 21.

13. Soroosh S, Davatchi F, Nadji A, Jamshidi AR, Chams- Davatchi C, Shams H, Shahram F, Akbarian M, Gharibdoost F, Ziaie N. HLA- B27 in Behcet’s Disease. XI. International conference on Behcet’s disease; 2004 October; Antalya, Turkey: S89.

14. Soroosh G S, Ghatfan A, Mehdipour F, Soroosh G M, Naderi A, Vahedi, H. The diagnostic value of synovial Biopsy(SB) and culture in chronic monoarthritis. Annual European Congress of Rheumatology 2005 June, Vienna: Ann Rheum Dis; 64: 374.

15. Soroosh G S, P Pasalar, Soroosh G M , Mehdipour F, Naderi A, Vahedi, Prospective studies on reactive arthritis in military service. Annual European Congress of Rheumatology 2006 June, Amesterdam: Ann Rheum Dis; Sup65: 270

16. Soroosh G S, John darmawan, Johannes J. Rasker, F, Davatchi, Soroosh G M, Dastjerdi F, Naderi A, Vahedi. The results of WHO- ILAR COPCORD stage II treatment of NSAID- refractory Ankylosing spondylitis by the step- down bridge protocol of intravenous and oral combination of 5 immunosuppressant. The 12th. Asia Pacific League of Associations for Rheumatology Congress; KL, Malaysia APLAR Journal of Rheumatology; Vol 9, Sup 1, 2006: A236.

17. Soroosh G S, John darmawan, Johannes J. Rasker, F, Davatchi, Soroosh G M, Dastjerdi F, Naderi A, Vahedi. The results of WHO- ILAR COPCORD stage II treatment of rheumatoid factor + rheumatoid arthritis by the step- down bridge protocol of IV and oral combination of 5 immunosuppressant. Asian Rheumatology “facing the challenges”. Aug 2006: 106.

18. Soroosh G S, John darmawan, Johannes J. Rasker, F, Davatchi, Soroosh G M, Dastjerdi F, Naderi A, Vahedi. The comparison of the results of WHO- ILAR COPCORD stage II treatment of of rheumatoid factor + rheumatoid arthritis by the step-down bridge protocol of IV and oral combination of 5 vesus 6 immunosuppressant. Asian Rheumatology “facing the challenges”. Aug 2006: 160.

19. Soroosh G S, Golestani A, Cawoosi M, Mogimi B, Ghandian N, Khaghani Sh, Nabatchian F, Pasalar P. Decreased Activity of Glutathione peroxidase in Ankylosing Spondylitis. 12th Asian chemical congress (12ACC). Aug 2007:329.

20. Ahmadreza Jamshidi, 1 Farhad Gharibdoost,1 Mahdi Vojdanian,1 Soosan G. Soroosh, et aliA phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis. Arthritis research and therapy. 2017. 19. 1682018 APLAR axial spondyloarthritis treatment recommendations.Lai Shan Tam 1, James Cheng-Chung Wei 2 3 4, Amita Aggarwal 5, Han Joo Baek 6, Peter P Cheung 7, Praveena Chiowchanwisawakit 8, Leonila Dans 9, Jieruo Gu 10, Noboru Hagino 11, Mitsumasa Kishimoto 12, Heizel Manapat Reyes 13, Soosan Soroosh 14, Simon Stebbings 15, Samuel Whittle 16, Swan Sim Yeap 17, Chak Sing Lau 18. Int J Rheum Dis 2019 Mar;22(3):340-356. doi: 10.1111/1756-185X.13510

21. Changes in BMD T-score from pre-to post-treatment with biosimilar teriparatide: A single-arm, multi-center study. MG Soroush, M Kheirandish, S Soroosh. Bone Reports 18, 101689

22. Investigation of cardiac complications and their incidence in patients with ankylosing spondylitis.M Soroush, M Mominzadeh, Y Ghelich, S Soroosh, Pashamedical archives 70 (1), 35

23. Investigating MA Relationship Between History and Physical Examination by Indicating MRI in Patients with Low Back Pain in Imam Reza Hospital MG Soroush, SG Soroosh, M Anari. Journal of Archives in Military Medicine 6 (1)

24. 2018 APLAR axial spondyloarthritis treatment recommendations. LS Tam, JCC Wei, A Aggarwal, HJ Baek, PP Cheung, ...International journal of rheumatic diseases 22 (3), 340-356

25. Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two …A Jamshidi, M Vojdanian, M Soroush, M Akbarian, M Aghaei, ...Arthritis Research & Therapy 24 (1), 161

26. Synovial biopsy for establishing a definite diagnosis in undifferentiated chronic knee monoarthritis. SG Soroosh, A Ghatfan, A Farbod, E Meftah. BMC Musculoskeletal Disorders2024 (1), 23

27. Musculoskeletal complaints and its economic impact in an Iranian army hospital SG Soroosh, A Farbod. BMC Musculoskeletal Disorders 2024,25 (1), 390

Chapter in Books ( in Farsi )

1. Soroosh G S, Extra articular manifestations pf Rheumatoid Arthritis. In: Akbarian M, (ed). Rheumatoid Disease, Tehran: Rheumatology Research Center; 1996. p. 63-75.

2. Soroosh G S, Mechanical non-discal back pain. In: Nadji A, (ed).Low Back Pain, Tehran: Rheumatology Research Center; 1997. p. 90-116.

3. Soroosh G S, Hip Osteoarthritis, In: Jamshidi A R, (ed). Arthrosis, Tehran: Rheumatology Research Center; 1999. p. 160-179.

4. Soroosh G S, Outcome of ocular involvement in Behcet’s Disease. In: Shahram F, (ed). Behcet’s Disease, Tehran: Rheumatology Research Center; 2000. p. 211-222.

5. Soroosh G S, Hip Periarthritis. In: Nadji A, (ed). Soft tissue rheumatism, Tehran: Rheumatology Research center; 2001. p. 270- 282.

6. Soroosh G S, Genetics in Systemic Lupus Erythematosus. In: Akbarian M, (ed). Systemic Lupus Erythematosus, Tehran: Rheumatology Research Center; 2002. p. 35- 43.

7. Soroosh G S, Bone mass physiology. In: Gharibdoost F, (ed). Osteoporosis, Tehran: Rheumatology Research Center; 2003. p. 150- 162.

8. Soroosh G S, Laboratory in vasculitis. In: Shahram F, (ed). Vasculitis, Tehran: Rheumatology Research Center; 2004. p. 35- 43.

9. Soroosh G S, Calcium pyrophosphate dehydrate disease. In: Jamshidi AR, (ed). Crystal induced arthropathy, Tehran: Rheumatology Research Center, 2004. p.

10. Soroosh G S, Neuroendocrin Axis. In: Akbarian M, (ed). Rheumatoid arthritis, Tehran: Rheumatology Research Center, 2006. p.

11. Soroosh G S, paraclinic test in Scc. In: Nadji A, Najafizadeh R (ed). Connective tissue disease, Tehran: Rheumatology Research Center, 2007. p.

12. Soroosh G S: Aids. In: Gharibdoost F, Moghadasi M(ed). Infectious disease in musculoskeletal diseases. Tehran Rheumatology Research Center, 2008.

13. Soroosh G S. Estrogen in treatment of osteoporosis.In: Shahram F, Moslemizadeh A(ed).New challenges in Rheumatology. Tehran: Rheumatology Research Center, 2009.

14. Soroosh G S. Benign Bone Tumor.In: Jamshidi A, Movasaghi S(ed).Rheumatic diseases of children.Tehran: Rheumatology Research Center, 2010.

15. Soroosh G S.Systemic lupus erythematosus. Neuroendocrn pathwayTehran: Rheumatology Research Center,In Akbarian M, Rostamian A. (ed) 2011.

16. Soroosh G S.Osteoarthritis. Osteoarthritis of hip. In: Nadji A, Akhlaghi M.(ed). Osteoarthritis.Tehran: Rheumatology Research Center, 2012.p.225- 235.

17. Soroosh G S.Scleroderma. Heart involvement. In Gharibdoost F, Eaezi T(ed). : Rheumatology Research Center, 2013.p.377-391.

18. Soroosh G S: Aids. In: Gharibdoost F, Moghadasi M(ed). Infectious disease in musculoskeletal diseases. Tehran Rheumatology Research Center, 2008.

19. Soroosh G S. Estrogen in treatment of osteoporosis.In: Shahram F, Moslemizadeh A(ed).New challenges in Rheumatology. Tehran: Rheumatology Research Center, 2009.

20. Soroosh G S. Benign Bone Tumor.In: Jamshidi A, Movasaghi S(ed).Rheumatic diseases of children.Tehran: Rheumatology Research Center, 2010.

21. Soroosh G S.Systemic lupus erythematosus. Neuroendocrn pathwayTehran: Rheumatology Research Center,In Akbarian M, Rostamian A. (ed) 2011.

22. Soroosh G S.Osteoarthritis. Osteoarthritis of hip. In: Nadji A, Akhlaghi M.(ed). Osteoarthritis.Tehran: Rheumatology Research Center, 2012.p.225- 235.

23. Soroosh G S.Scleroderma. Heart involvement. In Gharibdoost F, Faezi T(ed). : Rheumatology Research Center, 2013.p.377-391.

24. Soosan G soroosh. Rheumatic disease and pregnancy. In Shahram F, Dormohamadi T.: Rhematology research Center, 2014. P.471- 477.

25. Soosan G soroosh.biologic drugs in Rheumatic disease. Akhlaghi M: Rhematology research Center, 2015. P.471- 477.

26.

Books:

F.Davatchi, S.G.Soroosh, F.Sahram, H.Chams , M.Akbarian , F.

Gharibdoost , A.Nadji , C.Chams . Outcome measurement of ocular lesions in

Behcet ‘s Disease. In:Hamza M . (ed). Behcet’ s Disease, PUB ADHOUA ,Tunisia,

1997: p.238-41